share_log
  • Headlines
  • Syndax Pharma Sees FY24 Research and Development Expenses $245M to $250 M and Total Oper Expenses of $365 M to $370 M >SNDX

Syndax Pharma Sees FY24 Research and Development Expenses $245M to $250 M and Total Oper Expenses of $365 M to $370 M >SNDX

Dow Jones ·  05:34

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

Login or create a forever free account to read this news
Sign up/Log in
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated